Innovatus Capital Partners logo

Innovatus Capital Partners

North America, New York, United States, New York

Description

Innovatus Capital Partners is a Investment Adviser And Portfolio Management Firm.

Investor Profile

Innovatus Capital Partners has made 20 investments, with 2 in the past 12 months and 55% as lead.

Stage Focus

  • Post Ipo Debt (35%)
  • Series D (15%)
  • Series C (10%)
  • Post Ipo Equity (10%)
  • Series E (5%)
  • Series H (5%)
  • Series B (5%)
  • Series F (5%)
  • Debt Financing (5%)
  • Series Unknown (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Health Diagnostics
  • Therapeutics
  • Bioinformatics
  • Genetics
  • Cloud Computing
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Innovatus Capital Partners frequently co-invest with?

Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 3
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 3
Ascension Ventures
North America, Missouri, United States, Clarkton
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 3
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
D1 Capital Partners
North America, New York, United States, New York
Co-Investments: 2
AV
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does Innovatus Capital Partners often collaborate with?

TS
North America, Minnesota, United States, Minneapolis
Shared Deals: 1

What are some of recent deals done by Innovatus Capital Partners?

Imperative Care

Campbell, California, United States

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Health CareMedicalMedical Device
Series EJul 25, 2024
Amount Raised: $150,000,000
Celcuity

Hamel, Minnesota, United States

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo DebtMay 30, 2024
Amount Raised: $62,000,000
Codexis

Redwood City, California, United States

Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.

BiotechnologyChemicalSustainability
Post Ipo DebtFeb 13, 2024
Amount Raised: $40,000,000
JenaValve Technology

Irvine, California, United States

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

Health CareManufacturingMedical Device
Series CAug 31, 2022
Amount Raised: $100,000,000
MDxHealth

Irvine, California, United States

MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.

BiotechnologyHealth DiagnosticsMedical Device
Post Ipo DebtAug 2, 2022
Amount Raised: $35,000,000
Syapse

San Francisco, California, United States

Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care

Big DataBioinformaticsCloud ComputingHealth CareInformation ServicesInformation TechnologyPrecision Medicine
Series UnknownJul 27, 2022
Amount Raised: $35,000,000
Eiger BioPharmaceuticals

San Carlos, California, United States

Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.

BiotechnologyHealth CareMedical
Post Ipo EquityJun 7, 2022
Amount Raised: $5,000,000
Eiger BioPharmaceuticals

San Carlos, California, United States

Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.

BiotechnologyHealth CareMedical
Post Ipo DebtJun 7, 2022
Amount Raised: $75,000,000
DNAnexus

Mountain View, California, United States

DNAnexus develops a cloud platform and global network designed for scientific collaboration and accelerated discovery.

BioinformaticsBiotechnologyCloud ComputingMedicalSoftware
Series HMar 8, 2022
Amount Raised: $200,000,000
Apollo Endosurgery

Austin, Texas, United States

Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases.

BiotechnologyHealth CareMedical Device
Post Ipo DebtDec 21, 2021
Amount Raised: $35,000,000